Metrics as of 10/17/2026, 08:46 AM (Berlin time), refresh in progress.
Arecor Therapeutics Stock
Arecor Therapeutics plc
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United Kingdom
- CEO
- Sarah Jennifer Howell
- Employees
- 33
- Market cap
- £37 M
- IPO
- 03/06/2021
Arecor Therapeutics PLC is a biopharmaceutical enterprise dedicated to creating therapies for diabetes and various other medical conditions. The company utilizes its exclusive Arestat formulation technology platform to both cultivate its own range of specialized products (for diabetes and other ailments) and…
Arecor Therapeutics stock: price history
1D
+0.0%
1W
+13.8%
1M
-3.5%
6M
+25.0%
YTD
+2.5%
1Y
+6.5%
2Y
+11.5%
5Y
-79.9%
10Y
–
Next earnings date
Next earnings date
27/04/2027 (in 192 days)
Volatility around earnings
~173% stronger price swings than usual
Ask the agents about Arecor Therapeutics
Arecor Therapeutics stock metrics
P/E
165
P/B
8.46
EV/EBITDA
-6.88
RETURN ON EQUITY
-80.9%
NET MARGIN
-1,537.1%
DEBT/EQUITY
0.02
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
52.6%
FLOAT SHARES
23,714,166
AVG. DAILY VOLUME (30D)
33,682
Comparable stocks
Frequently asked questions about Arecor Therapeutics stock
What does Arecor Therapeutics do?
Arecor Therapeutics plc is a company in the Healthcare sector, Biotechnology industry, headquartered in United Kingdom.
The CEO is Sarah Jennifer Howell, the company employs around 33 people.
The IPO was on 03/06/2021; the stock trades on LSE under the ticker AREC.L.
When does Arecor Therapeutics report next?
The next earnings date is 27/04/2027.
Around past earnings, price swings were roughly 173% stronger than usual.
Does Arecor Therapeutics pay a dividend?
No, Arecor Therapeutics currently does not pay a dividend.
Which stocks are comparable to Arecor Therapeutics?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, argenx, Revolution Medicines, BeOne Medicines, Incyte and Genmab A/S.
How can I get Arecor Therapeutics stock analyzed?
Clicking "Analyze stock" lets five strategies assess Arecor Therapeutics against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.